BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165

Friday, December 23, 2022 1 min read

Key Takeaway: BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165